The Length Dependence of the PolyQ-mediated Protein Aggregation*

Polyglutamine (polyQ) repeat disorders are caused by the expansion of CAG tracts in certain genes, resulting in transcription of proteins with abnormally long polyQ inserts. When these inserts expand beyond 35–45 glutamines, affected proteins form toxic aggregates, leading to neuron death. Chymotrypsin inhibitor 2 (CI2) with an inserted glutamine repeat has previously been used to model polyQ-mediated aggregation in vitro. However, polyQ insertion lengths in these studies have been kept below the pathogenic threshold. We perform molecular dynamics simulations to study monomer folding dynamics and dimer formation in CI2-polyQ chimeras with insertion lengths of up to 80 glutamines. Our model recapitulates the experimental results of previous studies of chimeric CI2 proteins, showing high folding cooperativity of monomers as well as protein association via domain swapping. Surprisingly, for chimeras with insertion lengths above the pathogenic threshold, monomer folding cooperativity decreases and the dominant mode for dimer formation becomes interglutamine hydrogen bonding. These results support a mechanism for pathogenic polyQ-mediated aggregation, in which expanded polyQ tracts destabilize affected proteins and promote the formation of partially unfolded intermediates. These unfolded intermediates form aggregates through associations by interglutamine interactions.

[1]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[2]  Feng Ding,et al.  Reconstruction of the src-SH3 protein domain transition state ensemble using multiscale molecular dynamics simulations. , 2005, Journal of molecular biology.

[3]  Ulrich H. E. Hansmann,et al.  Protein-folding simulations in generalized ensembles , 2002 .

[4]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Ronald Wetzel,et al.  Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Andreas Vitalis,et al.  Characterizing the conformational ensemble of monomeric polyglutamine , 2005, Proteins.

[7]  B. Berne,et al.  The free energy landscape for β hairpin folding in explicit water , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Buldyrev,et al.  Folding Trp-cage to NMR resolution native structure using a coarse-grained protein model. , 2004, Biophysical journal.

[9]  Ronald Wetzel,et al.  Polyglutamine aggregation nucleation: Thermodynamics of a highly unfavorable protein folding reaction , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Feng Ding,et al.  Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases , 2005, PLoS Comput. Biol..

[11]  Samuel S. Cho,et al.  Domain swapping is a consequence of minimal frustration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Perutz,et al.  Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Mark R. Segal,et al.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.

[14]  C. Ross,et al.  Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.

[15]  Benny D. Freeman,et al.  Molecular Dynamics for Polymeric Fluids Using Discontinuous Potentials , 1997 .

[16]  Feng Ding,et al.  Topological determinants of protein domain swapping. , 2006, Structure.

[17]  Ronald Wetzel,et al.  Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions , 2006, Proceedings of the National Academy of Sciences.

[18]  C. Ross,et al.  Polyglutamine fibrillogenesis: The pathway unfolds , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Stanley,et al.  Discrete molecular dynamics studies of the folding of a protein-like model. , 1998, Folding & design.

[20]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[21]  Christopher M. Dobson,et al.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.

[22]  A. Fersht,et al.  Glutamine, alanine or glycine repeats inserted into the loop of a protein have minimal effects on stability and folding rates. , 1997, Journal of molecular biology.

[23]  Y. Sugita,et al.  Replica-exchange molecular dynamics method for protein folding , 1999 .

[24]  M. Perutz,et al.  Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  U. Hansmann Generalized ensemble techniques and protein folding simulations , 2002 .

[26]  H. Stanley,et al.  Direct molecular dynamics observation of protein folding transition state ensemble. , 2002, Biophysical journal.

[27]  P. Patterson,et al.  Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Hersch,et al.  Huntingtin aggregates may not predict neuronal death in Huntington's disease , 1999 .

[29]  D. C. Rapaport,et al.  The Art of Molecular Dynamics Simulation , 1997 .

[30]  V. Pande,et al.  Multiplexed-replica exchange molecular dynamics method for protein folding simulation. , 2003, Biophysical journal.

[31]  M. Perutz,et al.  Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Christopher A. Ross,et al.  Huntingtin Spheroids and Protofibrils as Precursors in Polyglutamine Fibrilization* , 2002, The Journal of Biological Chemistry.

[33]  José N Onuchic,et al.  A structural model of polyglutamine determined from a host-guest method combining experiments and landscape theory. , 2004, Biophysical journal.

[34]  R. Rosenfeld Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[35]  D. Neuhaus,et al.  Solution studies of chymotrypsin inhibitor-2 glutamine insertion mutants show no interglutamine interactions. , 2001, Biochemical and biophysical research communications.

[36]  G P Bates,et al.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Harry T Orr,et al.  Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. , 2006, Genes & development.